Claude Tendil has been President of the ARC Foundation for Cancer Research since June 2018, where he succeeded Michel Pébereau.
A graduate of HEC and Sciences Po, this former insurer, who has led groups such as Axa, Generali France or Europ Assistance, is a man of convictions and commitments.
He worked for a long time within the Dialogues association, which brings together business leaders and trade unionists, and Medef, where he was responsible for the social pole.
LE FIGARO.
- Does the Covid epidemic penalize research on other diseases?
Claude TENDIL.
-
The Covid has overshadowed cancer, which nevertheless remains by far the leading cause of death in France with, each year, nearly 158,000 deaths, 382,000 new cases detected and 3.8 million people living with cancer diagnosis.
Cancer is a major health issue, but with minor financial resources.
The research budget is unworthy of France: 180 million euros, of which more than 40% is
This article is for subscribers only.
You have 84% left to discover.
Subscribe: 1 € the first month
Can be canceled at any time
I ENJOY IT
Already subscribed?
Log in
